Docetaxel As Monotherapy or Combined With Ramucirumab or...

  • Main
  • 2016 / 02
  • Docetaxel As Monotherapy or Combined With Ramucirumab or...

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial

Petrylak, D. P., Tagawa, S. T., Kohli, M., Eisen, A., Canil, C., Sridhar, S. S., Spira, A., Yu, E. Y., Burke, J. M., Shaffer, D., Pan, C.-X., Kim, J. J., Aragon-Ching, J. B., Quinn, D. I., Vogelzang,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2015.65.0218
Date:
February, 2016
File:
PDF, 2.16 MB
english, 2016
Conversion to is in progress
Conversion to is failed